Sentry Investment Management LLC Cuts Position in UnitedHealth Group Incorporated $UNH

Sentry Investment Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 44.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,315 shares of the healthcare conglomerate’s stock after selling 1,855 shares during the period. UnitedHealth Group comprises 0.6% of Sentry Investment Management LLC’s holdings, making the stock its 26th largest position. Sentry Investment Management LLC’s holdings in UnitedHealth Group were worth $856,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Waterloo Capital L.P. lifted its holdings in UnitedHealth Group by 9.6% during the third quarter. Waterloo Capital L.P. now owns 6,060 shares of the healthcare conglomerate’s stock valued at $2,093,000 after purchasing an additional 531 shares in the last quarter. Homestead Advisers Corp lifted its stake in UnitedHealth Group by 14.7% in the 3rd quarter. Homestead Advisers Corp now owns 220,500 shares of the healthcare conglomerate’s stock valued at $76,139,000 after buying an additional 28,200 shares in the last quarter. Titleist Asset Management LLC increased its stake in UnitedHealth Group by 18.2% during the 3rd quarter. Titleist Asset Management LLC now owns 11,042 shares of the healthcare conglomerate’s stock worth $3,813,000 after buying an additional 1,699 shares in the last quarter. RMR Wealth Builders lifted its position in shares of UnitedHealth Group by 9.9% in the third quarter. RMR Wealth Builders now owns 1,104 shares of the healthcare conglomerate’s stock valued at $381,000 after acquiring an additional 99 shares in the last quarter. Finally, Border to Coast Pensions Partnership Ltd raised its stake in UnitedHealth Group by 14.2% in the 3rd quarter. Border to Coast Pensions Partnership Ltd now owns 207,338 shares of the healthcare conglomerate’s stock valued at $71,594,000 after purchasing an additional 25,786 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price for the company. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday. Finally, Jefferies Financial Group lowered their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Up 1.2%

Shares of UNH opened at $271.68 on Friday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36. The firm has a market cap of $246.10 billion, a P/E ratio of 20.57, a price-to-earnings-growth ratio of 1.27 and a beta of 0.41. The company’s 50-day moving average price is $326.94 and its 200 day moving average price is $323.01. The company has a current ratio of 0.79, a quick ratio of 0.82 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.22 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the firm earned $6.81 EPS. The business’s revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.